30 results
diagnosis differential management nephrology dm2 endocrinology medications metformin table algorithm cardiology comparison criticalcare dpp4 hematology high hyperkalemia inhibitors pathophysiology potassium
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents #Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... recommendations in renal ... #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment
Metformin Current Renal Dose Adjustments due to Risk of Lactic Acidosis > 60 No adjustment 45-60
Metformin Current Renal ... #Metformin #Renal ... #Dosing #Dose # ... Pharmacology #Diabetes
Vasopressors and Inotropes - Pharmacology Summary Vasopressors Phenylephrine (alpha-1) • Increases BP, SVR • Risk of reflex bradycardia
and Inotropes - Pharmacology ... Summary Vasopressors ... Phenylephrine ... • Higher doses cause ... 2 mcg/kg/min): renal
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products Insulin dosing can be
Insulin Dosing Basics ... For type 2 diabetes ... insulin for type 2 diabetes ... run into patient cases ... #Prescribing #Pharmacology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... agent • Does not cause ... #Summary #DM2 # ... diabetes #endocrinology
High Anion Gap Metabolic Acidosis (HAGMA) - Differential Diagnosis - GOLDMARK Glycols - ethylene and propylene glycol Oxoproline
L-lactate - produced during ... salicylate toxicity causes ... ketoacidosis Renal ... acids in advanced renal ... Ketoacidosis - diabetic
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... not definitively cause ... #Summary #DM2 # ... diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Inhibitors - Normal and Renal ... Dosing Increase ... patients have renal ... #Dosing #Pharmacology ... #Management #Diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... insulin in Type 1 Diabetes ... insulin dose for renal ... #Medications #pharmacology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... not definitively cause ... #Summary #DM2 # ... diabetes #endocrinology
No results found for "Phenylephrine summary pharmacology diabetes dosing renal causes"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Phenylephrine #summary #pharmacology #diabetes #dosing #renal #causes